PHENYLBUTAZONE 20% Solution

Šalis: Kanada

kalba: prancūzų

Šaltinis: Health Canada

Veiklioji medžiaga:

Phénylbutazone

Prieinama:

RAFTER 8 PRODUCTS INC

Dozė:

200MG

Vaisto forma:

Solution

Sudėtis:

Phénylbutazone 200MG

Vartojimo būdas:

Intraveineuse

Vienetai pakuotėje:

100ML

Recepto tipas:

Prescription

Farmakoterapinė grupė:

Chevaux; Chiens

Produkto santrauka:

Numéro de groupe d'ingrédients actifs (GIA) :0103526002

Autorizacija statusas:

COMMERCIALISÉ

Leidimo data:

2010-11-09

Pakuotės lapelis

September 13, 2023
VIAL LABEL (100 ML)
FRONT PANEL OF PULLOUT
Sterile/ Stérile
DIN 02333716
For Veterinary Use Only
Pour usage vétérinaire seulement
PHENYLBUTAZONE 20%
phenylbutazone injection, USP
injection de phénylbutazone, USP
100 mL
WARNINGS: KEEP OUT OF REACH OF CHILDREN. This drug is not to be
administered to
horses that are to be slaughtered for use in food.
MISES EN GARDE : GARDER HORS DE LA PORTÉE DES ENFANTS. Ce médicament
ne doit
pas être administré aux chevaux devant être abattus à des fins
alimentaires.
Rafter 8 Products Inc.
2920 Kingsview Blvd., Unit 3137, S.E.
Airdrie, AB T4A 0A9
AFTER OPENING PULLOUT:
Column 1
ACTIVE INGREDIENT (per mL): 200 mg phenylbutazone
Preservatives (per mL): 1 mg methyl parahydroxybenzoate; 0.1 mg propyl
parahydroxybenzoate
INDICATIONS:
Dog: As an aid in the treatment of bursitis, osteoarthritis,
arthritis, posterior weakness, posterior
paralysis, rheumatism, inflammation of the skin and other soft
tissues.
Horse: As an aid in the treatment of osteoarthritis of medial and
distal bones of the hock, arthritis
of the stifle and hip, arthritis of spine, chronic hip pains, chronic
pain in trapezius muscles and
generalized arthritis.
DOSAGE AND ADMINISTRATION: Inject slowly, intravenously.
Dog: 0.5 mL (100 mg) per 5 kg body weight daily. Total daily dosage
should not exceed 4 mL,
regardless of weight. Do not treat intravenously for more than 2
consecutive days.
Horse: 2.5-5 mL (0.5 – 1 g) per 250 kg body weight daily. Total
daily dose should not exceed 20
mL, regardless of weight. Do not treat intravenously for more than 5
consecutive days.
OWNERS SHOULD BE ADVISED WHEN THEIR DOG HAS RECEIVED A PHENYLBUTAZONE
INJECTION, AND
BE INFORMED OF THE POTENTIAL FOR ADVERSE REACTIONS AND CLINICAL SIGNS
ASSOCIATED WITH
NSAID INTOLERANCE.
CONTRAINDICATIONS: Do not administer to animals with cardiac, renal or
hepatic disease or those
with evidence of hemocytological disorders
CAUTION: Once the condition has regressed, treat strictly as required
or as recommended by a
veterinari